FBIOX vs. FHLC
Compare and contrast key facts about Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity MSCI Health Care Index ETF (FHLC).
FBIOX is managed by Fidelity. It was launched on Dec 16, 1985. FHLC is a passively managed fund by Fidelity that tracks the performance of the MSCI USA IMI Health Care Index. It was launched on Oct 21, 2013.
Performance
FBIOX vs. FHLC - Performance Comparison
Loading graphics...
FBIOX vs. FHLC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 2.11% | 36.38% | 7.26% | 10.09% | -15.87% | -12.26% | 38.62% | 36.12% | -10.92% | 27.87% |
FHLC Fidelity MSCI Health Care Index ETF | -4.22% | 15.42% | 2.48% | 2.58% | -5.55% | 20.39% | 18.13% | 21.94% | 4.71% | 23.34% |
Returns By Period
In the year-to-date period, FBIOX achieves a 2.11% return, which is significantly higher than FHLC's -4.22% return. Over the past 10 years, FBIOX has outperformed FHLC with an annualized return of 10.44%, while FHLC has yielded a comparatively lower 9.68% annualized return.
FBIOX
- 1D
- 5.51%
- 1M
- -1.00%
- YTD
- 2.11%
- 6M
- 15.61%
- 1Y
- 46.30%
- 3Y*
- 19.65%
- 5Y*
- 4.79%
- 10Y*
- 10.44%
FHLC
- 1D
- 0.78%
- 1M
- -5.85%
- YTD
- -4.22%
- 6M
- 3.95%
- 1Y
- 7.33%
- 3Y*
- 6.41%
- 5Y*
- 5.23%
- 10Y*
- 9.68%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBIOX vs. FHLC - Expense Ratio Comparison
FBIOX has a 0.69% expense ratio, which is higher than FHLC's 0.08% expense ratio.
Return for Risk
FBIOX vs. FHLC — Risk / Return Rank
FBIOX
FHLC
FBIOX vs. FHLC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and Fidelity MSCI Health Care Index ETF (FHLC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBIOX | FHLC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.70 | 0.42 | +1.27 |
Sortino ratioReturn per unit of downside risk | 2.26 | 0.70 | +1.57 |
Omega ratioGain probability vs. loss probability | 1.29 | 1.09 | +0.20 |
Calmar ratioReturn relative to maximum drawdown | 2.86 | 0.52 | +2.34 |
Martin ratioReturn relative to average drawdown | 11.00 | 1.19 | +9.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBIOX | FHLC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.70 | 0.42 | +1.27 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.19 | 0.35 | -0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.58 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.61 | -0.13 |
Correlation
The correlation between FBIOX and FHLC is 0.76, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBIOX vs. FHLC - Dividend Comparison
FBIOX's dividend yield for the trailing twelve months is around 2.42%, more than FHLC's 1.43% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 2.42% | 2.47% | 1.21% | 0.45% | 0.00% | 14.48% | 19.46% | 8.89% | 11.18% | 1.41% | 3.42% | 6.71% |
FHLC Fidelity MSCI Health Care Index ETF | 1.43% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
Drawdowns
FBIOX vs. FHLC - Drawdown Comparison
The maximum FBIOX drawdown since its inception was -71.98%, which is greater than FHLC's maximum drawdown of -28.76%. Use the drawdown chart below to compare losses from any high point for FBIOX and FHLC.
Loading graphics...
Drawdown Indicators
| FBIOX | FHLC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.98% | -28.76% | -43.22% |
Max Drawdown (1Y)Largest decline over 1 year | -12.27% | -10.38% | -1.89% |
Max Drawdown (5Y)Largest decline over 5 years | -44.87% | -17.73% | -27.14% |
Max Drawdown (10Y)Largest decline over 10 years | -48.66% | -28.76% | -19.90% |
Current DrawdownCurrent decline from peak | -2.21% | -7.27% | +5.06% |
Average DrawdownAverage peak-to-trough decline | -23.72% | -5.16% | -18.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.57% | 4.49% | -0.92% |
Volatility
FBIOX vs. FHLC - Volatility Comparison
Fidelity Select Biotechnology Portfolio (FBIOX) has a higher volatility of 9.24% compared to Fidelity MSCI Health Care Index ETF (FHLC) at 5.19%. This indicates that FBIOX's price experiences larger fluctuations and is considered to be riskier than FHLC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBIOX | FHLC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.24% | 5.19% | +4.05% |
Volatility (6M)Calculated over the trailing 6-month period | 15.54% | 10.06% | +5.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.47% | 17.61% | +6.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.93% | 14.85% | +10.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.43% | 16.82% | +9.61% |